GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Net Income Including Noncontrolling Interests

Novartis AG (MEX:NVS N) Net Income Including Noncontrolling Interests : MXN271,129 Mil (TTM As of Jun. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Novartis AG's Net Income Including Noncontrolling Interests for the three months ended in Jun. 2025 was MXN75,769 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2025 was MXN271,129 Mil.

Novartis AG Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Novartis AG's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Net Income Including Noncontrolling Interests Chart

Novartis AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160,548.33 492,705.25 135,594.68 252,135.48 248,996.20

Novartis AG Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59,467.05 62,713.61 58,813.07 73,833.64 75,768.70

Novartis AG Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN271,129 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Novartis AG's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XSWX:ROG XSWX:COPN LLY JNJ ABBV OCSE:NOVO B LSE:AZN MRK AMGN GILD PFE XPAR:SAN BMY TSE:4519 LSE:GSK SHSE:600276 TSE:4568 XTER:BAYN TSE:4578 BIIB
Traded in Other Exchanges
NVSEF:USA NVS:USA NOVN:Mexico 1NOVN:Italy NOVNz:UK 0K9E:UK 0QLR:UK NOT0:Germany NOTA:Germany NOT:Germany NOT:Germany NOTA:Germany NOT:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines